Saffron Capital Advisors Pvt Ltd ("Manager to the Open Offer") has submitted to BSE a copy of "Reminder Advertisement" dated August 06, 2025 to the Public Shareholders of Pharmaids Pharmaceuticals ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Saffron Capital Advisors, acting as Manager to the Open Offer, has submitted a Reminder Advertisement dated August 6, 2025 to BSE for public shareholders of Pharmaids Pharmaceuticals Ltd. The open offer is by Shankarappa Nagaraja Vinaya Babu (Acquirer) along with Tumkur Trade Center Private Limited (PAC) to acquire up to 91,69,632 equity shares of Rs. 10 each at a price of ₹62.15 per share, totalling approximately ₹56.99 crore. The reminder advertisement was published on August 7, 2025 in Financial Express (English, all editions), Jansatta (Hindi, all editions), Udaykala (Kannada, Bangalore edition), and Navshakti (Marathi, Mumbai edition). The offer is being made in compliance with SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.
This is a routine reminder to public shareholders of Pharmaids Pharmaceuticals that the open offer window is active. Eligible shareholders can tender their shares at ₹62.15 per share; however, they should independently assess the offer price versus prevailing market price before deciding to participate.